A prospective study of tuberculosis and HIV disease progression

被引:29
作者
Munsiff, SS
Alpert, PL
Gourevitch, MN
Chang, CJ
Klein, RS
机构
[1] Montefiore Med Ctr, Dept Med, Div Infect Dis, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Dept Epidemiol & Social Med, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
关键词
HIV; survival; tuberculosis; natural history;
D O I
10.1097/00042560-199812010-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine whether active tuberculosis alters the rate of progression of HIV infection in dually infected patients. Methods: HIV-seropositive patients at two Bronx, New York hospitals with tuberculosis confirmed by culture from July 1992 to February 1995, who survived the initial hospitalization for tuberculosis, were matched on gender, age, CD4(+) percentage, and calendar time with HIV-seropositive patients without tuberculosis participating in a study of the natural history of HIV infection. Patients received follow-up observation prospectively until May 23, 1995 to determine survival rates and development of AIDS-defining opportunistic infections (OIs). Results: 70 patients had tuberculosis; 120 did not. Mean CD4+ percentages were 12.4% and 12.5%, respectively. At study entry, 27% of those with tuberculosis had prior AIDS-defining OIs other than tuberculosis, compared with 10% of those without tuberculosis (p = .004). In multivariate survival analysis, controlling for CD4+ level, tuberculosis was not an independent predictor of increased other causes of AIDS-related mortality. However, in a logistic regression model, independent predictors of subsequent OIs included tuberculosis (hazard ratio, 4.1; 95% confidence intervals [CI], 1.9, 8.7), CD4(+) count <100/mm(3) (hazard ratio, 2.4; 95% CI, 1.1, 5.0) and prior OIs (hazard ration, 3.3; 95% CI, 1.3, 8.3). Conclusions: Tuberculosis was not an independent predictor of increased nontuberculosis-related mortality in HIV-seropositive patients but was associated with increased risk of development of OIs.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 22 条
[1]   2-YEAR INCIDENCE OF TUBERCULOSIS IN COHORTS OF HIV-INFECTED AND UNINFECTED URBAN RWANDAN WOMEN [J].
ALLEN, S ;
BATUNGWANAYO, J ;
KERLIKOWSKE, K ;
LIFSON, AR ;
WOLF, W ;
GRANICH, R ;
TAELMAN, H ;
VANDEPERRE, P ;
SERUFILIRA, A ;
BOGAERTS, J ;
SLUTKIN, G ;
HOPEWELL, PC .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (06) :1439-1444
[2]   A prospective study of tuberculosis and human immunodeficiency virus infection: Clinical manifestations and factors associated with survival [J].
Alpert, PL ;
Munsiff, SS ;
Gourevitch, MN ;
Greenberg, B ;
Klein, RS .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :661-668
[3]   EFFECTIVENESS OF SUPERVISED, INTERMITTENT THERAPY FOR TUBERCULOSIS IN HIV-INFECTED PATIENTS [J].
ALWOOD, K ;
KERULY, J ;
MOORERICE, K ;
STANTON, DL ;
CHAULK, CP ;
CHAISSON, RE .
AIDS, 1994, 8 (08) :1103-1108
[4]   CD4-PERCENT IS THE BEST PREDICTOR OF DEVELOPMENT OF AIDS IN A COHORT OF HIV-INFECTED HOMOSEXUAL MEN [J].
BURCHAM, J ;
MARMOR, M ;
DUBIN, N ;
TINDALL, B ;
COOPER, DA ;
BERRY, G ;
PENNY, R .
AIDS, 1991, 5 (04) :365-372
[5]  
*CDCP, 1992, MMWR-MORBID MORTAL W, V41, pRR17
[6]   RACE, SEX, DRUG-USE, AND PROGRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE [J].
CHAISSON, RE ;
KERULY, JC ;
MOORE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) :751-756
[7]  
DEAN AG, 1995, EPIINFO VERSION 6 02
[8]  
FRIEDLAND GH, 1991, J ACQ IMMUN DEF SYND, V4, P144
[9]  
GALAI N, 1995, J ACQ IMMUN DEF SYND, V8, P66
[10]  
Goletti D, 1996, J IMMUNOL, V157, P1271